Monday, April 22, 2013

What current regulatory, global, and public opinion trends have the potential to impact biologics?

Regulatory Affairs for Biologics
June 23 from 9:00AM – 5:00PM in Boston

Participants in this tutorial will learn the differences between traditional biologics and biotechnology products, the regulatory needs and requirements for biologics, the unique aspects in the development of specific biologics such as vaccines and gene therapy, and the different ways that CBER and CDER view product development.

Carol H. Danielson, DrPH,MS
Regulatory Advantage, United States

What’s more…Receive $100 off of your DIA 2013 Annual Meeting registration by registering for two half day tutorials or one full day tutorial. Please note purchases must be made at the same time in order to receive the discount.

Visit for more details on the DIA 2013 Annual Meeting being held June 23-27 in Boston, MA.

Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.

No comments:

Post a Comment